Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer
Craig M. Hooker(Lovelace Respiratory Research Institute), Malcolm V. Brock(Johns Hopkins University), Beverly Lee(Lovelace Respiratory Research Institute), Stephen C. Yang(Johns Hopkins University), Travis Brown(Johns Hopkins University), Joshua T. Taylor(Johns Hopkins University), Robert A. Meguid(University of Colorado Anschutz Medical Campus), Marc Sussman(Johns Hopkins University), Suvasini Laskshmanan(Johns Hopkins University), Avedis Meneshian(Johns Hopkins University), Jeanne Keruly(Johns Hopkins University), Richard D. Moore(Johns Hopkins University), John Wrangle(Johns Hopkins University), Alicia Hulbert(Johns Hopkins University), James Shin(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University)
Cited by 44
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration
|The Journal of Infectious Diseases|1987|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k